(Q35759136)

10 August 2017

1 reference

title

Pharmacokinetic optimisation of anticonvulsant therapy (English)

1 reference

10 August 2017

1 reference

A. H. Thomson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511537

3 October 2022

M. J. Brodie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1511537

3 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1511537

3 October 2022

publication date

1 September 1992

1 reference

Clinical Pharmacokinetics

10 August 2017

published in

1 reference

10 August 2017

volume

23

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

216-230

1 reference

Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses

10 August 2017

cites work

1 reference

12 December 2020

A comparison of phenytoin dosing methods in private practice seizure patients

1 reference

12 December 2020

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

1 reference

12 December 2020

Clinical pharmacokinetics of carbamazepine.

1 reference

12 December 2020

Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation

1 reference

12 December 2020

Clinical utility of a Bayesian dosing program for phenytoin.

1 reference

12 December 2020

Drug interactions that matter. A critical reappraisal

1 reference

12 December 2020

A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.

1 reference

12 December 2020

Pharmacokinetics of vigabatrin: implications of creatinine clearance

1 reference

12 December 2020

Factors influencing plasma phenobarbitone levels in epileptic patients

1 reference

12 December 2020

The pharmacokinetics of agents used to treat status epilepticus

1 reference

12 December 2020

1 reference

12 December 2020

Antiepileptic drugs: pharmacokinetic and clinical aspects.

1 reference

12 December 2020

Unusual absorption profile of phenytoin in a massive overdose case

1 reference

12 December 2020

Established anticonvulsants and treatment of refractory epilepsy

1 reference

12 December 2020

Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study

1 reference

12 December 2020

Management of epilepsy during pregnancy and lactation

1 reference

12 December 2020

Very-high-dose phenobarbital for refractory status epilepticus in children

1 reference

12 December 2020

Therapeutic drug monitoring of anticonvulsants. State of the art.

1 reference

12 December 2020

The Delayed Effect of Sodium Valproate on the Photoconvulsive Response in Man

1 reference

12 December 2020

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

1 reference

12 December 2020

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

12 December 2020

New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.

1 reference

12 December 2020

Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods.

1 reference

12 December 2020

1 reference

12 December 2020

Phenytoin clearances in a compliant population: description and application.

1 reference

12 December 2020

Comparison of eight phenytoin dosing methods in institutionalized patients.

1 reference

12 December 2020

Plasma level monitoring of anticonvulsants

1 reference

12 December 2020

Effect of source of population data on phenytoin dosage predictions in black patients

1 reference

12 December 2020

Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy

1 reference

12 December 2020

Drug metabolism in liver disease

1 reference

12 December 2020

Disposition of phenytoin in critically ill trauma patients

1 reference

12 December 2020

Carbamazepine metabolism in man. Induction and pharmacogenetic aspects

1 reference

12 December 2020

1 reference

12 December 2020

Acute effects of lamotrigine (BW430C) in persons with epilepsy

1 reference

12 December 2020

Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients

1 reference

12 December 2020

Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.

1 reference

12 December 2020

Predicting Phenytoin Dose—A Revised Nomogram

1 reference

12 December 2020

Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants

1 reference

12 December 2020

Drug treatment of epilepsy. Outlines, criticism and perspectives

1 reference

12 December 2020

Clinical utility of a new and simple technique for individualizing phenytoin dosage.

1 reference

12 December 2020

Phenytoin dosage individualization--five methods compared in the elderly.

1 reference

12 December 2020

Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose

1 reference

12 December 2020

1 reference

12 December 2020

Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine

1 reference

12 December 2020

New and potential anticonvulsants

1 reference

12 December 2020

Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy

1 reference

12 December 2020

Predicting individual phenytoin dosage

1 reference

12 December 2020

Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials

1 reference

12 December 2020

Serum-phenytoin levels in management of epilepsy

1 reference

12 December 2020

Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications

1 reference

12 December 2020

Diagnosis of epilepsy

1 reference

12 December 2020

Clinical experience with phenytoin prophylaxis in severe preeclampsia

1 reference

12 December 2020

Carbamazepine toxicity and poisoning. Incidence, clinical features and management

1 reference

12 December 2020

Current issues in the treatment of epilepsy

1 reference

12 December 2020

Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin

1 reference

12 December 2020

Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism

1 reference

12 December 2020

Optimal phenytoin therapy: A new technique for individualizing dosage

1 reference

12 December 2020

Carbamazepine substitution in severe partial epilepsy: implication of autoinduction of metabolism

1 reference

12 December 2020

Free and total serum valproate concentrations: their relationship to seizure control, liver enzymes and plasma ammonia in children

1 reference

12 December 2020

Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.

1 reference

12 December 2020

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy

1 reference

12 December 2020

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

1 reference

12 December 2020

Intravenous phenytoin: a loading scheme for desired concentrations

1 reference

12 December 2020

An updated comparison of drug dosing methods. Part I: Phenytoin

1 reference

12 December 2020

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

1 reference

12 December 2020

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

12 December 2020

Phenytoin dosage predictions in paediatric patients

1 reference

12 December 2020

Gabapentin as an antiepileptic drug in man

1 reference

12 December 2020

Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects

1 reference

12 December 2020

Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.

1 reference

12 December 2020

Pharmacokinetic drug interactions with phenytoin (Part II).

1 reference

12 December 2020

Pharmacokinetic drug interactions with phenytoin (Part I).

1 reference

12 December 2020

Graphic Estimation of Phenytoin Dose in Adults and Children

1 reference

12 December 2020

OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics

1 reference

12 December 2020

Psychomotor impairment and anticonvulsant therapy in adult epileptic patients.

1 reference

12 December 2020

Carbamazepine dose-frequency requirement in children

1 reference

12 December 2020

Status epilepticus in adults

1 reference

12 December 2020

Clinically relevant anti-epileptic drug interactions

1 reference

12 December 2020

Multiple-dose activate charcoal as adjunct therapy after chronic phenytoin intoxication

1 reference

12 December 2020

Clinical pharmacokinetics of valproic acid--1988.

1 reference

12 December 2020

Effects of Discontinuation of Phenytoin, Carbamazepine, and Valproate on Concomitant Antiepileptic Medication

1 reference

12 December 2020

Gas chromatographic measurement of plasma levels of sodium valproate: tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics

1 reference

12 December 2020

Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients

1 reference

12 December 2020

Treatment recommendations for anticonvulsant drug therapy in the older patient

1 reference

12 December 2020

Comparison of single-point phenytoin dosage prediction techniques.

1 reference

12 December 2020

Individualization of phenytoin dosage regimens

1 reference

12 December 2020

Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.

1 reference

12 December 2020

Individualizing phenobarbital dosing in neonates.

1 reference

12 December 2020

Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose

1 reference

12 December 2020

Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.

1 reference

12 December 2020

Comparison of methods of carbamazepine dosage, individualization in epileptic patients.

1 reference

12 December 2020

Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients

1 reference

12 December 2020

Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation

1 reference

12 December 2020

If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study

1 reference

12 December 2020

Rapid sequential phenobarbital treatment of neonatal seizures

1 reference

12 December 2020

Phenytoin pharmacokinetics in critically ill trauma patients

1 reference

12 December 2020

Gabapentin in partial epilepsy. UK Gabapentin Study Group

1 reference

12 December 2020

Fluctuations of carbamazepine concentrations during the day for two slow-release preparations.

1 reference

12 December 2020

Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.

1 reference

12 December 2020

Carbamazepine-10,11-epoxide in epilepsy. A pilot study

1 reference

12 December 2020

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

1 reference

12 December 2020

A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects

1 reference

12 December 2020

10.2165/00003088-199223030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1053010847

0 references

1 reference